The All Wales Medicines Strategy Group started the assessment of ivacaftor (Kalydeco) as soon as the drug company formally engaged with the appraisal process. This process is recognised to be robust and normally takes about 21 weeks to allow all parties, including patient organisations such as the Cystic Fibrosis Trust, to submit their comments. The final appraisal decision for Kalydeco is scheduled to be reached at a public meeting on 8th May 2013.
More top news
Back to normal it is! The continental temperatures we enjoyed last week are now replaced by a whole lot of average weather!
Coastguards say around 50 people a year in the UK getting into trouble in water after drinking.
UKIP's Neil Hamilton has called for party worker Llyr Powell to be sacked following comments he made about AMs living outside Wales.